ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

Comment on: "Relative Effectiveness and Safety of the GLP-1 Receptor Agonists, Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics" [Letter].

Huina Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.